The evidence highlights a critical linkage between Beclin-1-mediated autophagy and the efficacy of therapeutic agents in acute lymphoblastic leukemia (ALL), particularly influencing drug tolerance. The gene discussed is BECN1; the disease is acute lymphoblastic leukemia.